Discovery of multi-target receptor tyrosine kinase inhibitors as novel anti-angiogenesis agents

Lignende værker

• Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents
  af: Zhang, Lin, et al.
  Udgivet: (2017)
• Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
  af: Qin, Shuang, et al.
  Udgivet: (2019)
• Dominant Effect of Anti-angiogenesis in Combination Therapy Involving Cyclophosphamide and the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib
  af: Ma, Jie, et al.
  Udgivet: (2009)
• Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
  af: Zongru Jiang, et al.
  Udgivet: (2020-03-01)
• Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
  af: Jiang, Zongru, et al.
  Udgivet: (2020)